Spectral ai achieves 25% patient enrollment at emergency departments for u.s. burn pivotal study and adds two new clinical trial sites

Dallas, sept. 24, 2024 (globe newswire) -- spectral ai, inc. (nasdaq: mdai) (“spectral ai” or the “company”), an artificial intelligence (ai) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has achieved 25% patient enrollment at emergency departments (“ed”) for its u.s. burn pivotal study and added two new ed clinical trial sites for this study: medstar washington hospital center in washington, dc led by principal investigator shawn tejiram, md and the university of utah led by principal investigator giavonni lewis, md, facs. the addition of these two clinical research sites expands participating eds to 11 facilities.
MDAI Ratings Summary
MDAI Quant Ranking